# Xtent BioMedical LLC – FDA Inspection, Mar 5, 2026

Source: https://www.keypedia.com/records/fda_inspections/xtent-biomedical-llc/8d5afdd1-8798-457e-9434-c489c78485a1
Source feed: FDA_Inspections

> FDA inspection 1306782 of Xtent BioMedical LLC, March 05, 2026. 3 citations under 21 CFR part 1271. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1306782
- Company Name: Xtent BioMedical LLC
- Inspection Date: 2026-03-05
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New Orleans District Office
- Citation Count: 3

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/laressa-r-gray/fba337d5-35df-46fd-92fd-5068ef1c025f)
- [Issuing Officer](https://www.keypedia.com/people/laurissa-s-flowers/27453525-c2fc-4a05-9cdc-7a1ed884304f)

Company: https://www.keypedia.com/companies/xtent-biomedical-llc/897e8e73-1ebb-4f7d-9668-9c9e91e6936e

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea